晚期钆增强在致心律失常性右室心肌病中的预后价值:一项荟萃分析
该荟萃分析纳入5项研究共561例致心律失常性右室心肌病(ARVC)患者,评估心脏磁共振晚期钆增强(LGE)的预后价值。结果显示LGE阳性与全因死亡、主要不良心血管事件(MACE)、室性心动过速及植入心脏除颤器风险显著升高相关。LGE可作为ARVC患者不良预后的预测指标。
要点
- ARVC患者中LGE阳性提示全因死亡和MACE风险显著增加。
- LGE阳性还与室性心动过速和植入心脏除颤器风险升高相关。
- 阅读ARVC患者心脏MR时,应重视LGE的存在及范围。
关键影像表现/征象
- LGE阳性与LGE阴性ARVC患者在全因死亡率上存在显著差异(RR=4.78,95%CI 1.41-16.23,p=0.012)。
- LGE阳性与LGE阴性ARVC患者在MACE上存在显著差异(RR=2.48,95%CI 1.24-4.96,p=0.010)。
- LGE阳性与LGE阴性ARVC患者在室性心动过速上存在显著差异(RR=3.13,95%CI 1.69-5.78,p<0.001)。
- LGE阳性与LGE阴性ARVC患者在植入心脏除颤器上存在显著差异(RR=3.15,95%CI 1.69-5.87,p<0.001)。
临床应用与阅片要点
- 在ARVC患者心脏MR报告中,应明确描述LGE的存在与否,因其与不良预后相关。
- LGE阳性提示患者可能需要更密切的临床随访和风险分层。
局限性
- 纳入研究数量较少(仅5项),样本量有限(561例)。
- 未报告LGE的判读标准、扫描序列参数及不同中心的异质性来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess systematically the prognostic value of cardiac magnetic resonance imaging (CMRI) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC).
MATERIALS AND METHODS: The full text of studies of the clinical efficacy of late gadolinium enhancement (LGE) in ARVC was retrieved in multiple databases. Stata 14 was adopted for meta-analysis and bias analysis. Heterogeneity was assessed with the I2 statistic.
RESULTS: After exclusions, 561 patients were included in five studies, and the eligibility criteria were met. The meta-analysis suggested that there was a significant difference between LGE positive and negative patients with ARVC in all-cause mortality (relative risk [RR] = 4.78, 95% confidence interval [CI] = 1.41, 16.23, p=0.012; p for heterogeneity = 0.692, I2 = 0%); major adverse cardiovascular events (MACE) (RR=2.48, 95% CI = 1.24, 4.96, p=0.010; p for heterogeneity = 0.596, I2 = 0%); ventricular tachycardia (RR=3.13, 95% CI = 1.69, 5.78, p<0.001; p for heterogeneity = 0.825, I2 = 0%); implanted cardiac defibrillators (RR=3.15, 95% CI = 1.69, 5.87], p<0.001; p for heterogeneity = 0.353, I2 = 9.4%).
CONCLUSION: LGE in ARVC patients is a predictor of all-cause mortality and MACE.
引用
- Liu Y, Yu J, Liu J, et al. Prognostic value of late gadolinium enhancement in arrhythmogenic right ventricular cardiomyopathy: a meta-analysis. Clin Radiol. 2021. PMID: 34024635. doi:10.1016/j.crad.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。